Phase 4 clinical trial to examine the role of rosuvastatin and exercise treatment in modulating inflammatory response in hypercholesterolemic subjects.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 07 Oct 2006 New trial record.